Werkgroep Cardiologische centra Nederland

PARADISE-MI (Recruiting)

A multi-center, randomized, double-blind, active-controlled, parallel-group Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to Ramipril in acute MI patients with evidence of LV dysfunction (but without prior history of chronic HF)
Medicine
LCZ696
Population
ASCVD
Phase
III
Starting year
2016
More information
ClinicalTrials.gov

Director of Study

dr M.E. Emans (Cardioloog)
Rotterdam, Ikazia Ziekenhuis